Comparison of Depressive Symptoms among Women with Gynecological Cancer and other Cancer Types Before and during the COVID-19 Pandemic
International Neuropsychiatric Disease Journal, Volume 18, Issue 2,
Page 15-27
DOI:
10.9734/indj/2022/v18i2347
Abstract
Objective: Cancer patients are at a high risk of exhibiting depressive symptoms. However, what remains unknown is whether gynecological cancer (GC) worsens this risk. This study seeks to compare depressive symptoms amongst women diagnosed with GC and women diagnosed with other cancer types before COVID-19 pandemic and during the COVID-19 pandemic. It also seeks to compare both study periods to confirm if COVID-19 influenced depressive symptoms of women with GC.
Methods: A retrospective cross-sectional study was conducted to find an association between depressive symptoms and gynecological cancers using other cancer type diagnosis in females as a reference. We utilized the sample adult file of NHIS (National Health Interview Survey) data from 2019 (Pre-Pandemic data) and data from 2020 (Pandemic data). We also utilized the PHQ-8 scale to quantify major depressive disorder. Each of the 8 items were scored from 0-3. All statistical analysis were performed using SAS v9.4 ((SAS Institute Inc, Cary, NC), and statistical significance was set at α = 0.05.
Results: A weighted population of women with GC vs other cancer types was obtained. Women with GC tend to have lesser Age, Educational status, Health status, Income. They also tend to be more obese and smokers. Women with GC tend to have had hysterectomy (68.03% vs 35.43%) and access to care during COVID-19 (71.63% vs 68.01%). Severe depressive symptoms were higher before pandemic and among women with GC OR 2.89 (95%CI 1.64 - 5.12). Moderate depressive symptoms were higher during the pandemic and among women with GC OR 2.19 (95%CI 1.35 – 3.57). Among women with GC, depressive symptoms were less likely in 2020 than 2019 with an OR 0.57 (95%CI 0.36 – 0.91)
Conclusion: Based on the data available, women with gynecologic cancer are more prone to having depressive symptoms than women with other cancer types. Therefore, policies should be implemented to improve wellness of women with gynecologic cancer. Although, depressive symptoms wasn’t worsened by the COVID-19 pandemic.
- Depressive symptoms
- gynecological cancer
- psychiatric disorders
How to Cite
References
Mitchell AJ, Chan M, Bhatti H, Halton M, Grassi L, Johansen C et al. Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: A meta-analysis of 94 interview-based studies. Lancet Oncol. 2011;12(2):160-74.
Available: https://doi.org/10.1016/s1470-2045(11)70002-x
Pinquart M, Duberstein PR. Depression and cancer mortality: A meta-analysis. Psychol Med. 2010;40(11):1797-810.
Available:https://doi.org/10.1017/s0033291709992285
Sotelo JL, Musselman D, Nemeroff C. The biology of depression in cancer and the relationship between depression and cancer progression. Int Rev Psychiatry. 2014;26(1):16-30.
Available:https://doi.org/10.3109/09540261.2013.875891
Krebber AM, Buffart LM, Kleijn G, Riepma IC, Bree R, Leemans CR et al. Prevalence of depression in cancer patients: A meta-analysis of diagnostic interviews and self‐report instruments. Psycho Oncol. 2013;23(2):121-30.
Available: https://doi.org/10.1002/pon.3409
Walker J, Waters RA, Murray G, Swanson H, Hibberd CJ, Rush RW et al. Better off dead: suicidal thoughts in cancer patients. J Clin Oncol. 2008;26(29):4725-30.
Available:https://doi.org/10.1200/jco.2007.11.8844
Krebber AM, Buffart LM, Kleijn G, Riepma IC, Bree R, Leemans CR et al. Prevalence of depression in cancer patients: A meta-analysis of diagnostic interviews and self‐report instruments. Psycho Oncol. 2013;23(2):121-30.
Available: https://doi.org/10.1002/pon.3409
Satin JR, Linden W, Phillips MJ. Depression as a predictor of disease progression and mortality in cancer patients: a meta-analysis. Cancer. 2009;115(22):5349-61.
Available:https://doi.org/10.1002/cncr.24561
Klapheke AK, Keegan THM, Ruskin R, Cress RD. Depressive symptoms and health-related quality of life in older women with gynecologic cancers. J Geriatr Oncol. 2020;11(5):820-7.
Available:https://doi.org/10.1016/j.jgo.2019.10.001
Harnod T, Chen W, Wang JH, Lin SZ, Ding DC. Hysterectomies are associated with an increased risk of depression: A population-based cohort study. J Clin Med. 2018;7(10):366.
Available:https://doi.org/10.3390/jcm7100366
Wilson L, Pandeya N, Byles J, Mishra G. Hysterectomy and incidence of depressive symptoms in midlife women: the Australian Longitudinal Study on Women’s Health. Epidemiol Psychiatr Sci. 2017:1-12.
DOI: 10.1017/S2045796016001220
Gallagher S, Bennett KM, Roper L. Loneliness and depression in patients with cancer during COVID-19. J Psychosoc Oncol. 2021;39(3):445-51.
Available:https://doi.org/10.1080/07347332.2020.1853653
Moynihan R, Sanders S, Michaleff ZA, Scott AM, Clark J, To EJ, et al. Impact of COVID-19 pandemic on utilisation of healthcare services: a systematic review. BMJ Open. 2021;11(3):e045343.
DOI: 10.1136/bmjopen-2020-045343
Centers for Disease Control and Prevention. NHIS. Centers for Disease Control and Prevention. 2021; 2022, February 8. NHIS [cited Aug 6, 2022].
Available:https://www.cdc.gov/nchs/nhis/2021nhis.htm
Stordal E, Mykletun A, Dahl AA. The association between age and depression in the general population: A multivariate examination. Acta Psychiatr Scand. 2003;107(2):132-41.
Available: https://doi.org/10.1034/j.1600-0447.2003.02056.x
Gong TT, Wu QJ, Vogtmann E, Lin B, Wang YL. Age at menarche and risk of ovarian cancer: A meta-analysis of epidemiological studies. Int J Cancer. 2013;132(12):2894-900.
Available: https://doi.org/10.1002/ijc.27952
Marital satisfaction and marital status as a protective factor of depression and anxiety. REV ARGENT CLIN PSICOL. 2017.
Available:https://doi.org/10.24205/03276716.2017.1008
Lorant V, Croux C, Weich S, Deliège D, Mackenbach J, Ansseau M. Depression and socio-economic risk factors: 7-year longitudinal population study. Br J Psychiatry. 2007;190(4):293-8.
Available:https://doi.org/10.1192/bjp.bp.105.020040
Zare H, Meyerson NS, Nwankwo CA, Thorpe RJ. How income and income inequality drive depressive symptoms in U.S. adults, does sex matter: 2005-2016. Int J Environ Res Public Health. 2022;19(10):6227.
Available:https://doi.org/10.3390/ijerph19106227
Polanka BM, Vrany EA, Patel J, Stewart JC. Depressive disorder subtypes as predictors of incident obesity in US adults: moderation by race/ethnicity. Am J Epidemiol. 2017;185(9):734-42.
Available: https://doi.org/10.1093/aje/kwx030
Erving CL, Frazier C. The association between multiple chronic conditions and depressive symptoms: intersectional distinctions by race, nativity, and gender. J Health Soc Behav. 2021;62(4):599-617.
Available:https://doi.org/10.1177/00221465211040174
Eitle D, Eitle TMN. Obesity, overweightness, and depressive symptomology among American Indian Youth. J Racial Ethn Health Disparities. 2018;5(6):1305-14.
Available: https://doi.org/10.1007/s40615-018-0479-9
Byeon H. Association among smoking, depression, and anxiety: findings from a representative sample of Korean adolescents. PeerJ. 2015;3:e1288.
Available:https://doi.org/10.7717/peerj.1288
Kang HJ, Kim SY, Bae KY, Kim SW, Shin IS, Yoon JS et al. Comorbidity of depression with physical disorders: research and clinical implications. Chonnam Med J. 2015;51(1):8-18.
Available:https://doi.org/10.4068/cmj.2015.51.1.8
Smith E, Kneebone I. Assessment and psychological interventions for depression comorbid with cardiovascular disease. Cardiovasc Dis Depress. 2016:351-64.
Available: https://doi.org/10.1007/978-3-319-32480-7_20’
Whooley MA. Diagnosis and treatment of depression in adults with comorbid medical conditions: a 52-year-old man with depression. JAMA. 2012;307(17):1848-57.
Available: https://doi.org/10.1001/jama.2012.3466
Kroenke K, Strine TW, Spitzer RL, Williams JBW, Berry JT, Mokdad AH. The PHQ-8 as a measure of current depression in the general population. J Affect Disord. 2009;114(1-3):163-73.
Available:https://doi.org/10.1016/j.jad.2008.06.026
Dhingra SS, Kroenke K, Zack MM, Strine TW, Balluz LS. PHQ-8 Days: A measurement option for DSM-5 Major Depressive Disorder (MDD) severity. Popul Health Metr. 2011;9(1):11.
Available: https://doi.org/10.1186/1478-7954-9-11
Centers for Disease Control and Prevention. Gynecologic cancer incidence, United States-2012–2016. Centers for Disease Control and Prevention; 2019.
[Cited Aug 7, 2022].
Okoye G, Antwi H, Ben-Umeh KC, Vincent R. Comparison of healthcare resource utilization (HcRU) between age groups of women diagnosed with gynecological cancers in the United States. Int J Res Rep Gynaecol. 2022;5:106-14.
Iżycki D, Woźniak K, Iżycka N. Consequences of gynecological cancer in patients and their partners from the sexual and psychological perspective. Menopausal Rev. 2016;2:112-6.
Available:https://doi.org/10.5114/pm.2016.61194
The time and timing of work: unique challenges facing low-income families. Work-Fam Chall Low-Income Parents Child. 2014:119-28.
Available:https://doi.org/10.4324/9781410609755-13
Shirali E, Yarandi F, Ghaemi M, Montazeri A. Quality of life in patients with gynecological cancers: A web-based study. Asian Pac J Cancer Prev. 2020;21(7):1969-75.
Available:https://doi.org/10.31557/apjcp.2020.21.7.1969
Wichmann IA, Cuello MA. Obesity and gynecological cancers: A toxic relationship. Int J Gynaecol Obstet. 2021;155;Suppl 1:123-34.
Available:https://doi.org/10.1002/ijgo.13870
Jacob L, Freyn M, Kalder M, Dinas K, Kostev K. Impact of tobacco smoking on the risk of developing 25 different cancers in the UK: A retrospective study of 422,010 patients followed for up to 30 years. Oncotarget. 2018;9(25):17420-9.
Available:https://doi.org/10.18632/oncotarget.24724
Rubio-Guerra AF, Rodriguez-Lopez L, Vargas-Ayala G, Huerta-Ramirez S, Serna DC, Lozano-Nuevo JJ. Depression increases the risk for uncontrolled hypertension. Exp Clin Cardiol. 2013;18(1): 10-2.
PMID 24294029.
Thomson CA, Overholser LS, Hébert JR, Risendal BC, Morrato EH, Wheeler SB. Addressing cancer survivorship care under covid-19: perspectives from the cancer prevention and control research network. Am J Prev Med. 2021;60(5):732-6.
Available:https://doi.org/10.1016/j.amepre.2020.12.007
Nekhlyudov L, Duijts S, Hudson SV, Jones JM, Keogh J, Love B et al. Addressing the needs of cancer survivors during the COVID-19 pandemic. J Cancer Surviv. 2020;14(5):601-6.
Available: https://doi.org/10.1007/s11764-020-00884-w
Bell BA, Onwuegbuzie AJ, Ferron JM, Jiao QG, Hibbard ST, Kromrey JD. Use of design effects and sample weights in complex health survey data: a review of published articles using data from 3 commonly used adolescent health surveys. Am J Public Health. 2012;102(7):1399-405.
Available:https://doi.org/10.2105/ajph.2011.300398
Rosenman R, Tennekoon V, Hill LG. Measuring bias in self-reported data. Int J Behav Healthc Res. 2011;2(4):320-32.
Available:https://doi.org/10.1504/ijbhr.2011.043414
Sehouli J, Chekerov R, Keller M, Oskay-Oezcelik G, Braicu EI, Richter R. The impact of health related quality of life (hrqol) on short term survival of recurrent ovarian cancer patients: analysis of pooled data from the north-eastern German Society of Gynecological Oncology (NOGGO) meta data base. J Clin Oncol. 2018;36(15_suppl):5539.
Available:https://doi.org/10.1200/jco.2018.36.15_suppl.5539
Collins Y, Holcomb K, Chapman-Davis E, Khabele D, Farley JH. Gynecologic cancer disparities: A report from the Health Disparities Taskforce of the Society of Gynecologic Oncology. Gynecol Oncol. 2014;133(2):353-61.
-
Abstract View: 291 times
PDF Download: 43 times
